4Nomura T,Huang WC,Zhao HE,et al.β2-microglobulinmediated signaling as a target for cancer therapy[J].Anticancer Agents Med Chem,2014,14(3):343-352.
5Sasaki T,Ravindranath MH,Terasaki PI,et al.Gastric cancer progression may involve a shift in HLA-E profile from an intact heterodimer toβ2-microglobulin-free monomer[J].In J Cancer,2014,134(7):1558-1570.
6Naomi J W.The evolution of central nervous system prophylaxis for patients with acute lymphoblastic leukemia[J].Pediatr Blood,Cancer,2015,62(11):1877-1884.
7Erkut N.The Prognostic significance of soluble urokinase plasminogen activator receptor in acute myeloid leukemia[J].Turk J Haematol,2015,32(2):1012-1016.
8Tahara M,Yatera K,Yamasaki K,et al.Disseminated mycobacterium abscessus complex infection manifesting as multiple areas of lymphadenitis and skin abscess in the preclinical stage of acute lymphocytic leukemia[J].Intern Med,2016,55(13):1787-1791.
9Toh J,Eisenberg R,Bakirhan K,et al.Myelodysplastic syndrome and acute lymphocytic leukemia in common variable immunodeficiency(CVID)[J].J Clin Immunol,2016,36(4):366-369.
10Top K A,Pham-Huy A,Price V,et al.Immunization practices in acute lymphocytic leukemia and post-hematopoietic stem cell transplant in Canadian Pediatric Hematology/Oncology centers[J].Hum Vaccin Immunother,2016,12(4):931-936.
